Please assess the completion status of the following clinical trial:

Trial Title: Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 35-60,~* No antihypertensive treatment in the past or present,~* 135\< SBP\< 145 or 85\<DBP\<95,~* Informed consent signed,~Exclusion Criteria:~* Unwilling to participate in the study,~* Treated essential,~* secondary or complicated hypertension,~* SBP lower than 135 or higher than 145 mmHg,~* DBP lower than 85 or higher than 95 mmHg,~* Use of other medications (statins, NSAI ect..),~* Known allergy to tomato, carotenoids, or vitamin E,~* Diabetes Mellitus,~* Obesity BMI\>32,~* Significant dyslipidemia,~* Patients with ischemic pain, S/P MI, PTCA or CABG, LVH or CHF,~* Smoker,~* Valvular heart disease,~* PVD,~* Cerebrovascular disease, s/p CVA, TIA,~* Any kind of kidney disease (creatinine\>1.6),~* Chronic liver disease(elevated AST and ALT at least by 2 times of the normal range),~* Alcohol abuse,~* History of GI disease or surgery,~* History of malignancy in the past 5 years,~* History of autoimmune disease,~* Participation in other researches protocol

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): Lyc-o-Mato 5mg
- 3 (Type: ACTIVE_COMPARATOR): Lyc-o-Mato 15mg
- 4 (Type: ACTIVE_COMPARATOR): Lyc-o-Mato 30mg
- 5 (Type: ACTIVE_COMPARATOR): Lycopene capsules (non Lyc-o-mato) 15 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).